Infinant Health Announces Submission of Orphan Drug Designation Application

DAVIS, Calif., April 2, 2024 /PRNewswire/ — Infinant Health, a privately-held company focused on changing the trajectory of human health, one baby at a time, announced it has filed an application with the U.S. Food and Drug Administration (FDA) to receive Orphan Drug Designation (ODD)…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks